Navigation Links
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Date:1/22/2008

First and only medication approved to reduce both A1C and LDL cholesterol

PARSIPPANY, N.J., Jan. 22 /PRNewswire/ -- Daiichi Sankyo, Inc., announced that the United States Food and Drug Administration (FDA) has approved Welchol(TM) (colesevelam HCl) to improve glycemic control (measured as hemoglobin A1C) in adults with type 2 diabetes mellitus in combination with metformin, sulfonylureas, or insulin, either alone or in combination with other anti-diabetic agents. Welchol is now the first and only medication approved to reduce both glucose levels and low density lipoprotein cholesterol levels (LDL-C). The ADA estimates that 20.8 million people in the United States have diabetes with more than 90 percent of these people having type 2 diabetes.(1) Forty percent of patients with type 2 diabetes also have high LDL-cholesterol.(2) Welchol is a new option that addresses both these chronic health conditions and provides physicians with a unique therapeutic approach for treating patients with type 2 diabetes.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080122/NYTU059 )

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/welchol/29889/

Pivotal data presented at the American Diabetes Association's (ADA) 67TH Annual Scientific Sessions in Chicago in June, 2007 demonstrated that Welchol can lower both A1C and LDL-C levels in patients with type 2 diabetes who were uncontrolled on a metformin-based regimen. Patients in the study were randomly assigned to two groups. The addition of Welchol was compared to the addition of placebo in patients on a metformin-based regimen. The addition of Welchol (n=79) to pre-existing metformin monotherapy achieved a significant mean reduction in A1C levels of 0.47 percent relative to placebo (p<0.0024). Further, the total Welchol tr
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Today the U.S. Food and Drug Administration ... prevention of serogroup B meningococcal disease in ... Trumenba®, which received FDA approval in October, represent a ... "I have heard over and over ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... 2015 More than a third of reproductive-aged women enrolled ... private insurance, filled a prescription for an opioid pain medication ... week,s Morbidity and Mortality Weekly Report (MMWR). ... moderate to severe pain.  They are also found in some ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... 29, 2012 Nano Mask Inc., (NMI) (NANM.PK), a ... wellness related markets, today announced that it has ... Tamayz Medical, Inc. (the distributor), a Middle Eastern ... . Tamayz has agreed to purchase a minimum ...
... N.J., March 29, 2012  Aided by the launch of Rx-to-OTC ... allergy relief products grew 16.3% in 2011 to become the ... to the Nonprescription Drugs USA 2011 report by ... The U.S. OTC drug market posted a gain of 2.4% ...
Cached Medicine Technology:Nano Mask Enters Into Five Year $13,000,000 Middle East Distribution Agreement with Tamayz Medical 2Strong Rx-to-OTC Switch Performance and Holistic Marketing Drive Solid OTC Drug Market Growth in 2011, According to Kline 2Strong Rx-to-OTC Switch Performance and Holistic Marketing Drive Solid OTC Drug Market Growth in 2011, According to Kline 3
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... 2015 Four years since the release of their ... with the marriage of Avasa & Matthew Love – the duo ... scheduled for release through White Swan Records on February 24, 2015. ... a sacred path available to all of us to walk out ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... experts warn , SATURDAY, May 15 (HealthDay News) -- ... calling on parents to pay special heed to the ... eye protection is a concern for people of all ... and safety organization, warns that children are particularly vulnerable ...
... False Claims Act Attorney Tim ... of the Arizona Chapter of the Association of Certified Fraud Examiners on May 17. Terry ... fraud against the Government, and its unique Qui Tam provisions. , ... Phoenix, AZ (PRWEB) May 15, 2010 -- False Claims Act (FCA) attorney ...
... old, male testosterone levels drop by one to two percent ... diminish. Could there be a link between decreased testosterone and ... from the University of Montreal Department of Psychology, who presented ... pour le savoir (ACFAS). Sekerovic discovered a ...
... research facility at Riley Hospital for Children will dramatically ... research into new treatments for sick children, federal and ... $8.5 million to the Indiana University School of Medicine ... of the Clarian Health hospital into a state-of-the-art facility ...
... or more fare best, researchers say , FRIDAY, May 14 (HealthDay ... that "slow and steady" wins the race, but recent research suggests ... out losing 1.5 pounds a week or more on average and ... lost more slowly. They also maintained the loss longer and were ...
... ... in Various Stages of the RN Employment Lifecycle: Engagement, Retention and High-performance ... Charlotte, NC (Vocus) ... titled “Creating a High-Performing RN Workforce.” The free hour-long webinar will be broadcast ...
Cached Medicine News:Health News:Guard Kids' Eyes Against Long-Term Sun Damage 2Health News:False Claims Act Attorney Tim Terry to Address Arizona Chapter of the Association of Certified Fraud Examiners 2Health News:Middle-aged men: Could dwindling testosterone levels decrease sleep? 2Health News:Renovations at Riley Hospital for Children will boost pediatric clinical research 2Health News:Renovations at Riley Hospital for Children will boost pediatric clinical research 3Health News:Quick Weight Loss May Be Best for Long-Term Success 2Health News:Morehead Presents Webinar on &#8220;Creating a High-Performing RN Workforce&#8221; 2
... The Hgb Pro Professional Hemoglobin Testing ... and single-use test strips, used in measuring ... blood. The Hgb Pro provides the precision, ... require., ,The Hgb Pro Professional Hemoglobin Testing ...
... is a fully automated analyzer that requires ... time by the operator. The Variant II ... tubes. It reads the bar code, samples ... the specimen into the chromatographic station for ...
... The Advia 70 hematology system ... 5-part differential. Designed for speed ... analyzer combines cost-effectiveness with impressive ... suitable either on its own ...
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
Medicine Products: